BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29039056)

  • 21. Mesenchymal stem cell-based therapy for type 1 diabetes.
    Wu H; Mahato RI
    Discov Med; 2014 Mar; 17(93):139-43. PubMed ID: 24641956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy in type I diabetes. Approaches to prevention and treatment.
    Colman PG; Eisenbarth GS
    Postgrad Med; 1987 May; 81(6):146-55. PubMed ID: 3554198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune Mechanisms and Pathways Targeted in Type 1 Diabetes.
    Jacobsen LM; Newby BN; Perry DJ; Posgai AL; Haller MJ; Brusko TM
    Curr Diab Rep; 2018 Aug; 18(10):90. PubMed ID: 30168021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical heterogeneity of type 1 diabetes (T1D) found in Asia.
    Park Y; Wintergerst KA; Zhou Z
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28544229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease modifying therapies in type 1 diabetes: Where have we been, and where are we going?
    Lord S; Greenbaum CJ
    Pharmacol Res; 2015 Aug; 98():3-8. PubMed ID: 25771310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers for antigen immunotherapy in allergy and type 1 diabetes.
    Odegard JM; Nepom GT; Wambre E
    Clin Immunol; 2015 Nov; 161(1):44-50. PubMed ID: 26122171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies for clinical trials in type 1 diabetes.
    Ehlers MR
    J Autoimmun; 2016 Jul; 71():88-96. PubMed ID: 27068279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
    Endesfelder D; Hagen M; Winkler C; Haupt F; Zillmer S; Knopff A; Bonifacio E; Ziegler AG; Zu Castell W; Achenbach P
    Diabetologia; 2016 Oct; 59(10):2172-80. PubMed ID: 27400691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes.
    Bingley PJ; Wherrett DK; Shultz A; Rafkin LE; Atkinson MA; Greenbaum CJ
    Diabetes Care; 2018 Apr; 41(4):653-661. PubMed ID: 29559451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DiaPep277® and immune intervention for treatment of type 1 diabetes.
    Schloot NC; Cohen IR
    Clin Immunol; 2013 Dec; 149(3):307-16. PubMed ID: 24090708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Frontiers in the Treatment of Type 1 Diabetes.
    Warshauer JT; Bluestone JA; Anderson MS
    Cell Metab; 2020 Jan; 31(1):46-61. PubMed ID: 31839487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Life and death of β cells in Type 1 diabetes: A comprehensive review.
    Wilcox NS; Rui J; Hebrok M; Herold KC
    J Autoimmun; 2016 Jul; 71():51-8. PubMed ID: 27017348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulation for the prevention of SPIDDM and LADA.
    Pozzilli P; Guglielmi C
    Ann N Y Acad Sci; 2006 Oct; 1079():90-8. PubMed ID: 17130536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-IL-21 monoclonal antibody combined with liraglutide effectively reverses established hyperglycemia in mouse models of type 1 diabetes.
    Rydén AK; Perdue NR; Pagni PP; Gibson CB; Ratliff SS; Kirk RK; Friesen TJ; Haase C; Coppieters K; von Herrath MG; Boursalian TE
    J Autoimmun; 2017 Nov; 84():65-74. PubMed ID: 28711285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of type 1 diabetes: the time has come.
    Sherr J; Sosenko J; Skyler JS; Herold KC
    Nat Clin Pract Endocrinol Metab; 2008 Jun; 4(6):334-43. PubMed ID: 18446141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can we prevent type 1 diabetes?
    Beauchamp G; Haller MJ
    Curr Diab Rep; 2015 Nov; 15(11):86. PubMed ID: 26370697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 1 diabetes islet autoantibody markers.
    Winter WE; Harris N; Schatz D
    Diabetes Technol Ther; 2002; 4(6):817-39. PubMed ID: 12614488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy for type 1 diabetes.
    Frumento D; Ben Nasr M; El Essawy B; D'Addio F; Zuccotti GV; Fiorina P
    J Endocrinol Invest; 2017 Aug; 40(8):803-814. PubMed ID: 28260183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy for the prevention and treatment of type 1 diabetes.
    Goudy KS; Tisch R
    Int Rev Immunol; 2005; 24(5-6):307-26. PubMed ID: 16318984
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.